Eradication of Helicobacter pylori increases platelet count in patients with idiopathic thrombocytopenic purpura in Japan
Authors:
- 25 February 2005
- journal article
- research article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 35 (3) , 214-219
Abstract
Background The effect of Helicobacter pylori eradication on the platelet count in patients with thrombocytopenic purpura is controversial. In this multicentre study, we prospectively assessed the effect of H. pylori eradication therapy in idiopathic thrombocytopenic purpura patients.Materials and methods Thirty‐five consecutive patients with chronic idiopathic thrombocytopenic purpura (11 males and 24 females, a median age of 57) were assessed for H. pylori infection by use of a urea breath test. All patients received 1‐week triple therapy (amoxicillin, clarithromycin, and lansoprazole) to eradicate H. pylori. At 6 months, idiopathic thrombocytopenic purpura patients with a platelet count recovery of greater than 100 × 109 L−1 were defined as idiopathic thrombocytopenic purpura responders.Results Helicobacter pylori infection was observed in 25 (71%) of the 35 patients. All infected patients were cured. Eleven patients were identified as idiopathic thrombocytopenic purpura responders; 24 were considered nonresponders. Platelet counts improved by more than 100 × 109 L−1 in 11 (44%) of the 25 patients cured of H. pylori infection, while none of the 10 patients H. pylori‐negative patients experienced the same improvement (P = 0·015). Univariate analysis showed that H. pylori infection and its eradication were significant factors associated with platelet recovery (P = 0·015).Conclusions Helicobacter pylori infection played a role in the pathogenesis of idiopathic thrombocytopenic purpura in approximately 30% of all patients assessed and 45% of the patients with H. pylori infection. Eradication of H. pylori in idiopathic thrombocytopenic purpura patients led to improved disease activity.Keywords
This publication has 28 references indexed in Scilit:
- Does Helicobater pylori initiate or perpetuate immune thrombocytopenic purpura?Blood, 2004
- Evaluation of the Effects of Strain-Specific Antigen Variation on the Accuracy of Serologic Diagnosis of Helicobacter pylori InfectionJournal of Clinical Microbiology, 2003
- A New Serum Antibody Test Kit (E Plate) for Evaluation of Helicobacter Pylori Eradication.Internal Medicine, 2002
- Regression of autoimmune thrombocytopenia after eradication of Helicobacter pyloriThe Lancet, 1998
- Thrombocytopenia in the Sepsis SyndromeThe American Journal of Medicine, 1997
- Diagnosis and Treatment of Idiopathic Thrombocytopenic Purpura: Recommendations of the American Society of HematologyAnnals of Internal Medicine, 1997
- Molecular mimicry between Helicobacter pylori and the hostTrends in Microbiology, 1997
- Long-Term observation of 208 adults with chronic idiopathic thrombocytopenic purpuraThe American Journal of Medicine, 1995
- Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese populationGastroenterology, 1992
- Quantification of Platelet-Associated IgG with Competitive Solid-Phase Enzyme ImmunoassayActa Haematologica, 1981